Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risedronate in Fibrous Dysplasia of Bone
NCT00445575Phase 3Completed
- Sponsor
- Inserm
- Start
- Jul 2007
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of risedronate in fibrous dysplasia of bone (FD), sponsored by Inserm. Started Jul 2007; status: completed.
02
Drugs
risedronate
03
Conditions
fibrous dysplasia of bone (FD)
Beyond the preview
Go deeper on NCT00445575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00445575.